Novartis Advances $23B US Manufacturing Plan in Florida

Novartis to Build Fourth US Radioligand Therapy Facility to Strengthen Supply Chain

The pharma giant will invest in a 35,000-square-foot RLT manufacturing site in Winter Park, FL as part of its $23 billion US infrastructure expansion.

Novartis advances $23B US manufacturing plan in Florida

The basics: Novartis plans $70M radioligand therapy manufacturing facility in Winter Park, Fla. 35,000-sf site will mark company’s 4th US RLT facility Project part of Novartis’ $23B investment to expand U.S. manufacturing, R&D Facility will support time-sensitive cancer therapies for patients in the Southeast Amid an effort to boost its U.S.-based manufacturing capabilities, Novartis is building a state-of-the-art radioligand therapy manufactur…

Novartis to build fourth US radioligand therapy facility in Florida

Novartis has announced plans to construct a new US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.